Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 377

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 377
---

    Toovey
     
    Director

    518
    (7)

    *

    Paul
    Field
     
    Director

    518
    (8)

    *

    Officers
    and Directors as a Group (total of 7 persons)

    33,868

    2.30
    %

*Less
than 1%

    (1)
    Percentages based on 1,472,891 shares of common stock issued and outstanding
as of March 27, 2025 plus shares of common stock the person has the right to acquire within 60 days thereafter. Unless otherwise indicated,
the principal address of the named executives and directors is c/o 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036. On February
24, 2025, the Company effectuated a 1-for-5 Reverse Stock Split of its outstanding common stock. Accordingly, all share numbers presented
in this table have been adjusted to reflect the Reverse Stock Split.

    (2)
    Includes
    (i) 4,471 shares of our common stock held in the name of Geoffrey Dow, (ii) 11,120 shares of common stock held by the Geoffrey S.
    Dow Revocable Trust (the “Dow Trust”), of which Geoffrey Dow is the trustee and has control over the voting and disposition
    of the shares of common stock held by the Dow Trust, (iii) 175 shares of common stock issuable upon exercise of warrants issued to
    the Geoffrey S. Dow Revocable Trust and (iv) 1,000 shares underlying fully vested options exercisable into common stock at a per
    share exercise price of $60.00.

    (3)
    Includes (i) 5,274 shares
    of our common stock held in the name of Tyrone Miller, and (ii) 800 shares underlying fully vested options exercisable into common
    stock at a per share exercise price of $60.00.

    (4)
    Ms. Landon beneficially
    owns a total of 5,374 shares of common stock, of which includes (i) 4,540 shares of common stock held in the name of Ms. Landon,
    and (ii) 834 shares underlying fully vested options exercisable into common stock at a per share exercise price of $6.85.

    (5)
    Mr. Allen beneficially
    owns a